Shahab Juhi, Ahuja Sana, Singh Mukul, Verma Pooja, Ranga Sunil
Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.
Cytojournal. 2024 Feb 9;21:7. doi: 10.25259/Cytojournal_22_2023. eCollection 2024.
In an era of minimally invasive and rapid diagnostic technologies, fine-needle aspiration cytology (FNAC) is most useful when it comes to patients with lymphadenopathies especially of the cervical region. Liquid-based cytology (LBC) is an alternative processing method which is used for both gynecological and non-gynecological samples. Because of the remarkable advantages of LBC smears in gynecological samples, nowadays, many studies have been done to assess its utility in various other lesions. Hereby, with the help of this study, we would like to evaluate the efficiency of LBC smears in comparison to conventional FNAC smears conventional smears (CS) on lymph node aspirates.
A retrospective study was done over a 1-year period in which 253 cases of lymph node aspirates were included in the study. The slides were prepared using standard conventional and LBC techniques and compared for adequacy, cellularity, cell architecture, necrosis, background debris, presence of cells in monolayer sheets, and nuclear/cytoplasmic details.
Of the total 253 cases, 171 (67.6%) were and 67 (26.5%) were diagnosed as non-neoplastic and malignant, respectively. Although the LBC smears were useful in the diagnosis of malignant cases, they did pose some challenges especially in the non-neoplastic lymph node aspirates due to loss of the background necrosis. In addition, the cellular yield in LBC smears was low in comparison to CS.
LBC smears from lymph node aspirates results in better diagnostic accuracy for malignant cases due to better cellular and nuclear details. However, for non-neoplastic etiology, it should not be considered better than CS as loss of the background necrosis and inflammation may result in an incorrect diagnosis.
在微创和快速诊断技术的时代,细针穿刺细胞学检查(FNAC)对于患有淋巴结病尤其是颈部淋巴结病的患者最为有用。液基细胞学检查(LBC)是一种可用于妇科和非妇科样本的替代处理方法。由于LBC涂片在妇科样本中具有显著优势,如今,已开展了许多研究来评估其在各种其他病变中的效用。在此,借助本研究,我们希望评估LBC涂片与传统FNAC涂片(常规涂片,CS)相比在淋巴结穿刺液中的效率。
进行了一项为期1年的回顾性研究,该研究纳入了253例淋巴结穿刺液病例。使用标准的传统和LBC技术制备玻片,并比较其充分性、细胞数量、细胞结构、坏死情况、背景碎片、单层片中细胞的存在情况以及核/质细节。
在总共253例病例中,分别有171例(67.6%)和67例(26.5%)被诊断为非肿瘤性和恶性。尽管LBC涂片在恶性病例的诊断中有用,但它们确实带来了一些挑战,特别是在非肿瘤性淋巴结穿刺液中,因为背景坏死消失了。此外,与CS相比,LBC涂片的细胞产量较低。
淋巴结穿刺液的LBC涂片由于细胞和核细节更好,对恶性病例的诊断准确性更高。然而,对于非肿瘤性病因,由于背景坏死和炎症的消失可能导致错误诊断,因此不应认为它比CS更好。